Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (121-130 of 185) with videos related to

Pageof 19
Sort By:
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 20, 1999
Frequencies of platelet-specific alloantigen systems 1-5 in three distinct ethnic groups in BrazilV Castro, A F Origa, J M Annichino-Bizzacchi, et al.
The Journal of Clinical Investigation|May 3, 2003
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transferFederico Mingozzi, Yi-Lin Liu, Eric Dobrzynski, et al.
Blood Cells, Molecules & Diseases|February 8, 2000
Mutation analysis of the HFE gene in Brazilian populationsM F Agostinho, V R Arruda, D S Basseres, et al.
Blood|October 14, 2004
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelValder R Arruda, Hansell H Stedman, Timothy C Nichols, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2009
Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemiaErich V de Paula, Mariane Cristina Flores-Nascimento, Valder R Arruda, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Blood|June 26, 2004
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX geneDenise E Sabatino, Elina Armstrong, Shyrie Edmonson, et al.
Blood|January 9, 2015
AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and miceJulie M Crudele, Jonathan D Finn, Joshua I Siner, et al.
Environmental Monitoring and Assessment|December 29, 2018
Multi-temporal accumulation and risk assessment of available heavy metals in poultry litter fertilized soils from Rio de Janeiro upland regionCláudio E T Parente, Adan S Lino, Elias R Arruda Junior, et al.
Blood|February 7, 2001
Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoterJ N Hagstrom, L B Couto, C Scallan, et al.
Pageof 19

Showing results (121-130 of 185) with videos related to

Sort By:
Pageof 19
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 20, 1999
Frequencies of platelet-specific alloantigen systems 1-5 in three distinct ethnic groups in BrazilV Castro, A F Origa, J M Annichino-Bizzacchi, et al.
The Journal of Clinical Investigation|May 3, 2003
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transferFederico Mingozzi, Yi-Lin Liu, Eric Dobrzynski, et al.
Blood Cells, Molecules & Diseases|February 8, 2000
Mutation analysis of the HFE gene in Brazilian populationsM F Agostinho, V R Arruda, D S Basseres, et al.
Blood|October 14, 2004
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal modelValder R Arruda, Hansell H Stedman, Timothy C Nichols, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 21, 2009
Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemiaErich V de Paula, Mariane Cristina Flores-Nascimento, Valder R Arruda, et al.
Blood|August 25, 2012
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapyJonathan D Finn, Timothy C Nichols, Nikolaos Svoronos, et al.
Blood|June 26, 2004
Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX geneDenise E Sabatino, Elina Armstrong, Shyrie Edmonson, et al.
Blood|January 9, 2015
AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and miceJulie M Crudele, Jonathan D Finn, Joshua I Siner, et al.
Environmental Monitoring and Assessment|December 29, 2018
Multi-temporal accumulation and risk assessment of available heavy metals in poultry litter fertilized soils from Rio de Janeiro upland regionCláudio E T Parente, Adan S Lino, Elias R Arruda Junior, et al.
Blood|February 7, 2001
Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoterJ N Hagstrom, L B Couto, C Scallan, et al.
Pageof 19